More on HROW

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-145.8% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Harrow Health (NQ:HROW)
Delayed: 42.87 +0.93 (2.22%)
Prev. Close $41.94  
Open$42.63 
52 Wk High$ 
52 Wk Low$ 
Day High$42.98 
Day Low$41.25 
P/E N/A  
EPS$ 
Volume1,071,358 


Jun 10, 2026 07:01 AM Harrow re-launches VERKAZIA eye drops for pediatric eye condition
Jun 10, 2026 07:00 AM Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare
Jun 3, 2026 09:16 AM Form 8-K HARROW, INC. For: Jun 03
May 27, 2026 07:00 AM Harrow to Present at William Blair’s 46th Annual Growth Stock Conference
May 19, 2026 07:00 AM Form 4 HARROW, INC. For: May 18 Filed by: SILVERNAIL LAUREN P
May 19, 2026 07:00 AM Form 4 HARROW, INC. For: May 18 Filed by: Graves Adrienne L
May 18, 2026 05:00 PM Form 4 HARROW, INC. For: May 15 Filed by: Shojaei Amir
May 15, 2026 07:01 AM Form 4 HARROW, INC. For: May 14 Filed by: BAUM MARK L
May 15, 2026 07:01 AM Form 4 HARROW, INC. For: May 14 Filed by: BOLL ANDREW R.
May 14, 2026 08:55 AM Harrow Health (HROW) PT Lowered to $60 at B.Riley
View All Articles

Entities mentioned with HROW

View All Entities